About this conference
ICLTHVH is a 1-day conference in Hangzhou, China on 15 Jan 2027. Abstract deadline: 14 Dec 2026. Fees: 149 - 270 USD. Organizer: Society for Engineering and Research.
Scholars and healthcare practitioners convene to exchange insights on long-acting therapeutics for HIV and viral hepatitis, examining the latest innovations in treatment approaches. This event emphasizes the significance of interdisciplinary collaboration, welcoming contributions in the form of original research, abstracts, and case studies. Presentations will highlight advancements in therapeutic efficacy, patient adherence strategies, and technology's role in drug administration. Participants can expect in-depth discussions, networking opportunities, and panel debates centered around improving clinical outcomes and addressing barriers to access. A special focus will be placed on implementation science and population health strategies addressing disparities in healthcare. Join a dedicated community of professionals committed to advancing therapeutic options through the lens of current scientific research and practical applications. This is an opportunity to deepen understanding of the evolving landscape of long-acting therapies and their impact on patient care and public health.